Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI-46 PET/CT in Sarcoma
NCT04457258Phase 1Active, not recruiting
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Sep 2020
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga FAPI-46 in sarcoma, sponsored by UCLA Jonsson Comprehensive Cancer Center. Primary endpoint: Biodistribution of 68Ga-FAPi-46. Started Sep 2020; status: active, not recruiting.
02
Drugs
68Ga FAPI-46
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT04457258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04457258.